Advertisement
Singapore markets closed
  • Straits Times Index

    3,332.80
    -10.55 (-0.32%)
     
  • Nikkei

    39,583.08
    +241.54 (+0.61%)
     
  • Hang Seng

    17,718.61
    +2.14 (+0.01%)
     
  • FTSE 100

    8,194.05
    +14.37 (+0.18%)
     
  • Bitcoin USD

    60,756.49
    -994.51 (-1.61%)
     
  • CMC Crypto 200

    1,270.79
    -13.04 (-1.01%)
     
  • S&P 500

    5,510.60
    +27.73 (+0.51%)
     
  • Dow

    39,395.84
    +231.78 (+0.59%)
     
  • Nasdaq

    17,943.57
    +84.89 (+0.48%)
     
  • Gold

    2,336.40
    -0.20 (-0.01%)
     
  • Crude Oil

    81.25
    -0.49 (-0.60%)
     
  • 10-Yr Bond

    4.2920
    +0.0040 (+0.09%)
     
  • FTSE Bursa Malaysia

    1,590.09
    +5.15 (+0.32%)
     
  • Jakarta Composite Index

    7,063.58
    +95.63 (+1.37%)
     
  • PSE Index

    6,411.91
    +21.33 (+0.33%)
     

A Look At The Intrinsic Value Of Symrise AG (ETR:SY1)

Key Insights

  • The projected fair value for Symrise is €104 based on 2 Stage Free Cash Flow to Equity

  • Symrise's €113 share price indicates it is trading at similar levels as its fair value estimate

  • Analyst price target for SY1 is €115, which is 11% above our fair value estimate

Does the June share price for Symrise AG (ETR:SY1) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by projecting its future cash flows and then discounting them to today's value. We will use the Discounted Cash Flow (DCF) model on this occasion. It may sound complicated, but actually it is quite simple!

Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you.

ADVERTISEMENT

Check out our latest analysis for Symrise

Crunching The Numbers

We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate:

10-year free cash flow (FCF) estimate

2024

2025

2026

2027

2028

2029

2030

2031

2032

2033

Levered FCF (€, Millions)

€469.9m

€503.5m

€554.4m

€616.5m

€657.3m

€689.1m

€713.8m

€733.2m

€748.6m

€761.1m

Growth Rate Estimate Source

Analyst x9

Analyst x9

Analyst x7

Analyst x2

Est @ 6.61%

Est @ 4.83%

Est @ 3.59%

Est @ 2.72%

Est @ 2.10%

Est @ 1.68%

Present Value (€, Millions) Discounted @ 5.4%

€446

€454

€474

€500

€506

€504

€495

€483

€468

€452

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = €4.8b

The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 0.7%. We discount the terminal cash flows to today's value at a cost of equity of 5.4%.

Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = €761m× (1 + 0.7%) ÷ (5.4%– 0.7%) = €16b

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= €16b÷ ( 1 + 5.4%)10= €9.7b

The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is €15b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of €113, the company appears around fair value at the time of writing. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.

dcf
dcf

Important Assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Symrise as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.4%, which is based on a levered beta of 1.017. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for Symrise

Strength

  • Earnings growth over the past year exceeded the industry.

  • Debt is well covered by earnings and cashflows.

  • Dividends are covered by earnings and cash flows.

Weakness

  • Dividend is low compared to the top 25% of dividend payers in the Chemicals market.

  • Expensive based on P/E ratio and estimated fair value.

Opportunity

  • Annual revenue is forecast to grow faster than the German market.

Threat

  • Annual earnings are forecast to grow slower than the German market.

Looking Ahead:

Whilst important, the DCF calculation shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. For Symrise, we've compiled three essential aspects you should further research:

  1. Risks: Be aware that Symrise is showing 1 warning sign in our investment analysis , you should know about...

  2. Future Earnings: How does SY1's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the XTRA every day. If you want to find the calculation for other stocks just search here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com